The Wall Street Journal says to expect "an uptick in acquisitions of small and midsize drug companies" but that large pharma companies are "not going on reckless shopping sprees." Bristol-Myers' Karen LaRochelle said that many in Big Pharma do have a bit of cash "and there's a lot of pressure for us to build our pipelines." Merck's Richard Kender adds that, due to the current market, deals that in the past may have been deemed "marginal" are now more likely.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.